Aemetis’ (AMTX) “Buy” Rating Reiterated at HC Wainwright

HC Wainwright restated their buy rating on shares of Aemetis (NASDAQ:AMTX) in a research note released on Friday,Benzinga reports. They currently have a $28.00 price target on the specialty chemicals company’s stock.

Separately, StockNews.com raised shares of Aemetis to a “sell” rating in a report on Wednesday, February 5th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $14.56.

Aemetis Stock Performance

Shares of NASDAQ:AMTX opened at $1.68 on Friday. The company has a market capitalization of $85.94 million, a P/E ratio of -0.74 and a beta of 1.48. Aemetis has a fifty-two week low of $1.50 and a fifty-two week high of $7.03. The company’s 50-day moving average is $2.18 and its 200 day moving average is $2.67.

Institutional Investors Weigh In On Aemetis

Several hedge funds and other institutional investors have recently modified their holdings of AMTX. FMR LLC increased its position in shares of Aemetis by 68.2% during the third quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock valued at $52,000 after buying an additional 9,137 shares during the period. State Street Corp increased its position in shares of Aemetis by 36.1% in the third quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock worth $1,608,000 after purchasing an additional 185,304 shares during the last quarter. Wellington Management Group LLP bought a new position in shares of Aemetis in the third quarter worth approximately $177,000. Barclays PLC increased its position in shares of Aemetis by 274.6% in the third quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock worth $109,000 after purchasing an additional 34,816 shares during the last quarter. Finally, Geode Capital Management LLC increased its position in shares of Aemetis by 7.7% in the third quarter. Geode Capital Management LLC now owns 924,293 shares of the specialty chemicals company’s stock worth $2,126,000 after purchasing an additional 66,031 shares during the last quarter. 27.02% of the stock is currently owned by institutional investors.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.